Description
PRIME DECA 500 – Nandrolone Decanoate 500mg/ml
PRIME DECA 500 is a high-concentration formulation of Nandrolone Decanoate, designed for advanced users who demand optimized dosing efficiency and minimal injection frequency. Delivering 500mg per ml, this preparation allows for significant anabolic support with lower injection volumes—improving compliance during long-term protocols.
Key Advantages of Higher Concentration:
The elevated dosage per ml minimizes total injection volume, reducing site irritation and improving comfort over prolonged cycles. For experienced users managing multi-compound stacks, this concentration enhances precision in dose planning while freeing up syringe capacity for adjunct compounds.
Primary Applications:
Well-regarded for its ability to promote steady lean mass gains, joint support, and improved recovery, Nandrolone Decanoate is particularly effective in strength-building or rehabilitation-focused regimens. It is frequently paired with testosterone esters to maintain hormonal balance and optimize anabolic response.
Clinical Considerations:
Due to its impact on prolactin levels, periodic monitoring is advised. Recommended exclusively for seasoned users who understand the implications of long-acting compounds and higher concentrations.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.